ReviewTransfusion medicine reviews2017
Challenges and Research in Managing Blood Supply in China.
Review in Transfusion medicine reviews, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed.
- Leveraging Behavioral Sciences to Augment Voluntary Blood Donation in China: A Randomized Control Trial and Latent Class Analysis.International journal of behavioral medicine · 2026Trial
- Federated multimodal learning for privacy-preserving blood donor profiling and personalized recall strategy optimization.Scientific reports · 2026Article
- Blood donation trends in Zhejiang Province, 2017-2025: an ecological study before, during, and after COVID-19.Frontiers in public health · 2026Article
- Article
- Blood Service in a Region of China's Qinghai-Tibetan Plateau.Healthcare (Basel, Switzerland) · 2023Article
- Blood Donors' Preferences Toward Incentives for Donation in China.JAMA network open · 2023Article
- The development of a legal framework for blood donation and blood safety in China over 24 years.BMC health services research · 2020Article
- Population-based projections of blood supply and demand, China, 2017-2036.Bulletin of the World Health Organization · 2020Article
- Blood donation from 2006 to 2015 in Zhejiang Province, China: annual consecutive cross-sectional studies.BMJ open · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Although considerable progress has been made in improving the blood service system in China over the last 2 decades, many challenges remain. A number of issues have received public attentions; however, others continue to be underacknowledged and controversial. This article describes 3 of these important and less emphasized issues: first, the ambiguity of the definition of voluntary nonremunerated blood donation and its relationship to an adequate blood supply; second, the current inadequacies of cost recovery from the blood service system; and third, the lack of a universally implemented program of hemovigilance. Currently, there is controversy regarding these challenges. Open recognition and discussion offers the prospect of bringing solutions closer to reality.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.